SMS (2175) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
28 Apr, 2026Executive summary
Net sales for FY03/26 reached ¥64,735 million (+6.2% YoY), driven by growth in Career and Elderly/Disability Care businesses, but results fell short of initial plans due to underperformance in Career and Overseas segments.
Operating income was ¥6,787 million (+7.1% YoY), EBITDA ¥11,406 million (+11% YoY), and ordinary profit ¥8,721 million (+4.4% YoY).
A ¥22,957 million impairment loss in the Overseas Business led to a net loss of ¥14,317 million for the year.
Dividend per share increased to ¥29.5 for FY03/26, with a further rise to ¥30.5 forecast for FY03/27.
Governance enhancements include establishing the Corporate Value Improvement Committee (CVIC) and a revamped Board structure.
Financial highlights
Gross profit reached ¥57,132 million, up from ¥53,854 million YoY.
Cash and cash equivalents at year-end were ¥12,547 million, down ¥2,705 million from the previous year.
Net assets fell to ¥26,724 million from ¥47,319 million, reflecting share repurchases and impairment losses.
Equity-to-asset ratio declined to 50.2% from 61.5%.
Net loss: ¥14,317 million due to impairment loss.
Outlook and guidance
FY03/27 is positioned as a foundational year with net sales guidance of ¥71,834 million (+11% YoY), EBITDA of ¥10,400 million (−9% YoY), and operating income of ¥6,801 million (+0.2% YoY).
Strategic investments of ¥2.0 billion planned for CP recruitment, DR sales/customer success, and Kabenashi Cloud sales.
Dividend per share projected to rise to ¥30.5 for FY03/27.
Latest events from SMS
- Sales and profit grew, led by domestic businesses, while overseas sales declined.2175
Q3 202630 Jan 2026 - Profits rose 36% year-over-year, driven by domestic growth and new CEO appointment.2175
Q2 202628 Oct 2025 - Net income jumped 25% YoY, with strong domestic growth and new performance-based share rights.2175
Q1 202629 Jul 2025 - Sales up 16% YoY, profits down; double-digit growth forecast for full year.2175
Q2 202513 Jun 2025 - Q1 sales up 15% YoY, profits down on higher costs; growth and share buyback expected.2175
Q1 202513 Jun 2025 - Double-digit sales and profit growth forecast for FY03/26 amid strong market demand.2175
Q4 20256 Jun 2025 - Profits and forecasts cut as competition rises, but dividend and disability JV grow.2175
Q3 20255 Jun 2025